Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariadna Gifreu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMJ Neurology Open|December 23, 2025
Cardiac involvement in anti-GABA-B receptor encephalitis: a case reportRosa Ferrer Tarrés, Alexis García Sarreón, Francisco Pozo Ariza, et al.
Frontiers in Psychiatry|February 13, 2025
Assessment of clinical prognosis in autoimmune encephalitis: Girona scoreGary Álvarez Bravo, Giuseppe Guglielmini, Ana Quiroga Varela, et al.
Frontiers in Neurology|July 8, 2022
Verbal Learning and Longitudinal Hippocampal Network Connectivity in Temporal Lobe Epilepsy SurgeryJacint Sala-Padro, Ariadna Gifreu-Fraixino, Júlia Miró, et al.
Journal of Neuroimmunology|March 7, 2026
Morvan syndrome associated with prominent Tau pathology: A clinicopathological case reportGary Álvarez Bravo, Rosa Ferrer Tarrés, Andreu Vilaseca Jolonch, et al.
Brain Sciences|September 28, 2021
Risk of Developing Epilepsy after Autoimmune EncephalitisAriadna Gifreu, Mercè Falip, Jacint Sala-Padró, et al.
Frontiers in Immunology|May 13, 2026
A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive declineAlbert Miguela, Joana Maria Huertas-Pons, Clàudia Coll-Martinez, et al.
Epilepsia Open|August 30, 2025
Effectiveness and safety of early add-on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: BRIV-add studyPedro J Serrano-Castro, Fernando Caballero-Martínez, Francisco J Campos-Lucas, et al.
Epilepsia|October 15, 2024
Amyloid deposition in adults with drug-resistant temporal lobe epilepsyElena Fonseca, Sofía Lallana, Gemma Ortega, et al.
Epilepsy & Behavior : E&B|August 27, 2023
Real-life evidence about the use of intravenous brivaracetam in urgent seizures: The BRIV-IV studyVicente Villanueva, Xiana Rodriguez-Osorio, Álvaro Juiz-Fernández, et al.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMJ Neurology Open|December 23, 2025
Cardiac involvement in anti-GABA-B receptor encephalitis: a case reportRosa Ferrer Tarrés, Alexis García Sarreón, Francisco Pozo Ariza, et al.
Frontiers in Psychiatry|February 13, 2025
Assessment of clinical prognosis in autoimmune encephalitis: Girona scoreGary Álvarez Bravo, Giuseppe Guglielmini, Ana Quiroga Varela, et al.
Frontiers in Neurology|July 8, 2022
Verbal Learning and Longitudinal Hippocampal Network Connectivity in Temporal Lobe Epilepsy SurgeryJacint Sala-Padro, Ariadna Gifreu-Fraixino, Júlia Miró, et al.
Journal of Neuroimmunology|March 7, 2026
Morvan syndrome associated with prominent Tau pathology: A clinicopathological case reportGary Álvarez Bravo, Rosa Ferrer Tarrés, Andreu Vilaseca Jolonch, et al.
Brain Sciences|September 28, 2021
Risk of Developing Epilepsy after Autoimmune EncephalitisAriadna Gifreu, Mercè Falip, Jacint Sala-Padró, et al.
Frontiers in Immunology|May 13, 2026
A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive declineAlbert Miguela, Joana Maria Huertas-Pons, Clàudia Coll-Martinez, et al.
Epilepsia Open|August 30, 2025
Effectiveness and safety of early add-on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: BRIV-add studyPedro J Serrano-Castro, Fernando Caballero-Martínez, Francisco J Campos-Lucas, et al.
Epilepsia|October 15, 2024
Amyloid deposition in adults with drug-resistant temporal lobe epilepsyElena Fonseca, Sofía Lallana, Gemma Ortega, et al.
Epilepsy & Behavior : E&B|August 27, 2023
Real-life evidence about the use of intravenous brivaracetam in urgent seizures: The BRIV-IV studyVicente Villanueva, Xiana Rodriguez-Osorio, Álvaro Juiz-Fernández, et al.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
Pageof 2